In this study, we present compelling evidence in vitro and in vivo, highlighting the potential of AAG as a modulator of glycogen‐driven ATP production that can attenuate the detrimental effects of jellyfish venom on CF. This evidence concerns the gene MPG and cystic fibrosis.